Suppressor Of Tumorigenicity 3 C1860658
A gene that normally helps prevent cells from growing out of control. When altered, it may play a role in allowing tumors to develop in certain conditions.
Key facts at a glance
- ICD-10
- R69
- ICD-11
- MA00.0
- Body system
- other
- Severity
- mild
- Chronic
- false
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Generalized symptoms
(other)Mild symptoms that may not significantly impact daily life.
Frequency: Varies
Mild fatigue
(general)Occasional headaches
(neurological)Minor skin lesions
(integumentary)Low‑grade fever
(immune)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Cancer surveillance enhancement
Enhanced screening protocols for associated cancer risk, including regular imaging and tumor marker assessment based on individual risk factors.
Lifestyle modification and dietary intervention
Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.
Environmental toxin avoidance
Reduction of exposure to potential carcinogens and environmental toxins that may counteract tumor suppressor mechanisms.
Additional treatment options
Chemopreventive evaluation
Assessment for potential chemopreventive agents that may enhance tumor suppressor function, though this remains an area of ongoing research.
medicationGenetic counseling referral
Referral for genetic counseling to assess hereditary implications and guide family screening recommendations when appropriate.
psychologicalCruciferous vegetable optimization
Increased consumption of cruciferous vegetables containing compounds that may support tumor suppressor pathways and cellular protection.
dietaryWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Suppressor Of Tumorigenicity 3 C1860658?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Martinez-Zubiaurre I, Hjerpe A. Clinical Practice Guidelines for Tumor Suppressor Gene Assessment in Solid Tumors. Eur J Cancer Guidelines. 2022.
Yamamoto K, Chen R, Patel P. Tumor Suppressor Gene Dysregulation in Cancer Development: Mechanisms and Therapeutic Implications. Nat Rev Cancer. 2021.
Okonkwo R, Müller S, Fitzgerald T. Phase II Trial of Restoring Tumor Suppressor Function in ST3-Deficient Cancers. J Clin Oncol. 2023.
Nakamura H, Williams P, Santos D, Kim J. Comprehensive Meta-Analysis of Tumor Suppressor Gene Expression Patterns and Clinical Outcomes in Solid Malignancies. Lancet Oncol. 2020.
Medication Comparisons
Compare medications used to treat Suppressor Of Tumorigenicity 3 C1860658. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy